medigraphic.com
ISSN 1560-4381 (Print)

2016, Number 3

<< Back Next >>

Correo Científico Médico 2016; 20 (3)

Clinical evaluation in children with allergic rhinitis treated with montelukast

Álvarez PO, Parra CM, Martínez RR, Ochoa RTZ, Chapman TM

Language: Spanish
References: 30
Page: 452-467
PDF size: 395.58 Kb.


ABSTRACT

Introduction: Allergic rhinitis is an IgE-mediated inflammation of the nasal mucosa induced after allergen exposure and presents with the 3 cardinal symptoms of sneezing, nasal obstruction, and rhinorrhea. Allergic rhinitis is a global health problem and is increasing in prevalence.
Objective: to evaluate the effectiveness of montelukast in children with persistent allergic rhinitis in the "Rene Avila Reyes" Polyclinic, in Holguín, from October 2012 to February 2013.
Methods: a prospective analytical study was performed including 20 patients aged from 6 to 19 years old. The variables analyzed in the study were: sex, age, other allergicdiseases, nasal symptoms in the day, symptoms in the night, and ocular symptoms in the day and total eosinophils. For comparative analysis we used the McNemar test p=0.01.
Results: 12 patients (60.0%) of male sex were found, 16 (80.0%) with Bronchial Asthma and 8 (40.0%) with atopic dermatitis. Before the treatment 20 patients had nasal itch, 16 had nasal obstruction and 1 patient had normal levels of eosinophils. After treatment with montelukast 1 patient (5.0%) had nasal itch and nasal obstruction and 3 patients had high levels of eosinophils.
Conclusions: in the population had prevalence of male patients, adolescents and with Bronchial Asthma. Montelukast was effective for managing and control of symptoms the patients with Allergic Rhinitis.


REFERENCES

  1. De Freitas HA, Rodríguez Galafat J, Mujica L, de De Freitas MT. Asociación entre rinitis alérgica y asma. RFM. 2009 [citado 1 6 may 2016]; 32 (1): 7-10. Disponible en: http://www.scielo.org.ve/scielo.php?script=sci_arttext&pid=S0798-04692009000100002&lng=es

  2. Álvarez MJ, Olaguíbel JM, Lasa E, Arroabarren E, Gómez A, Gómez B. De la rinitis al asma: ¿una o dos enfermedades? Anales Sis San Navarra. 2003 [citado may 16 2016]; 26 (Supl2): 49-55. Disponible en: http://recyt.fecyt.es/index.php/ASSN/article/view/4988/4236

  3. Olivares Elegia MP, Pérez Pacareu M, Naranjo Robalino RM. Historia y aspectos sociales de la alergología en Cuba. Rev Cubana Sal Púb. 2011[citado 16 may 2016]; 37(3): 338-348. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662011000300014&lng=es

  4. Natt RS, Karkos PD, Natt DK, Theochari EG, Karkanevatos A. Treatment trends in allergic rhinitis and asthma: a British ENT survey. BMC Ear Nose Throat Disord. 2011[citado 15 mar 2013]; 11.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090350/

  5. Lozano A, Croce VH. Consenso Nacional de Rinitis Alérgica en Pediatría. Arch Argent Pediatr. 2009[citado 18 may 2016]; 107(1):67-81.Disponible en: http://sap.org.ar/docs/profesionales/consensos/v107n1a16.pdf

  6. Álvarez Castelló M, García Gómez IM, Castro Almarales R, Ronquillo Díaz M. Rinitis alérgica y rinosinusitis: Una revisión necesaria. Rev Cubana Med Gen Integr. 2004 [citado 14 feb 2013]; 20(1).Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252004000100007&lng=es

  7. Alam B, Goksor E, Thengilsdottir H, Pettersson R, Mollborg P, Norvenius G.Early protective and risk factors for alllergic rhinitis at age 4 1/2 yr. Pediatr Allergy Immunol. 2011[citado 14 feb 2013]; 22(4):398–404.Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3038.2011.01153.x/full

  8. Keil T, Bockelbrink A, Riech A, Hoffmann U, Kamin W, Forster J, et al. The natural history of allergic rhinitis in childhood. Pediatr Allergy Immunol. 2010[citado 14 feb 2013]; 21(6):962–969.Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3038.2010.01046.x/abstract?deniedAccessCustomisedMessage=&userIsAuthenticated=false

  9. Lagos JA, Marshal GD. Montelukast in the management of allergic rhinitis. Ther Clin Risk Manag. 2007 [citado 14 feb 2013]; 3(2):327-332.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936314/

  10. Medina AP, Olaya FJ, Navas MP, Tilano AM, Muñoz E. Estudio de bioequivalencia de montelukast en tabletas masticables de 5 mg. Biomédica. 2012[citado 14 feb 2013]; 32(3): 399-407.Disponible en: http://www.revistabiomedica.org/index.php/biomedica/article/view/708

  11. Montelukast. Rev Cubana Far. 2012[citado 9 feb 2013]; 46(3):375-380.Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152012000300010&lng=es

  12. Bérubé D, Djandji M, Sampalis JS, Becker A. Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study. Allergy Asthma Clin Immunol.2014 [citado 9 feb 2015]; 10(1):21.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057588/

  13. Venero Fernández SJ, Varona Pérez P, Fabret Ortiz D, Suárez Medina R, Bonet Gorbea M, Molina Esquivel E, et al. Asma bronquial y rinitis en escolares de Ciudad de La Habana 2001 a 2002.Rev Cubana Hig Epidemiol. 2009[citado 9 feb 2013]; 47(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30032009000100005&lng=es

  14. Bousquet J, Schünemann HJ, Samolinski B, Demoly P, Baena Cagnani CE, Bachert C, et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012[citado 13 feb 2013]; 130(5):1049-1062. Disponible en: http://www.jacionline.org/article/S0091-6749(12)01306-1/fulltext

  15. Calderon MA, Demoly P, Gerth van Wijk R, Bousquet J, Sheikh A, Frew A, et al. EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy. 2012[citado 13 feb 2013]; 2. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514324/

  16. Valovirta E, Myrseth SE, Palkonen S. The voice of the patients: allergic rhinitis is not a trivial disease. Curr Opin Allergy Clin Immunol. 2008[citado 13 feb 2013]; 8(1): 1–9. Disponible en: http://journals.lww.com/co-allergy/Abstract/2008/02000/The_voice_of_the_patients__allergic_rhinitis_is.2.aspx

  17. da Cunha IbiapinaI C, Cavalcanti SarinhoII ES, Moreira Camargos PA, Ribeiro de Andrade C, Souza da Cruz Filho AA. Rinite alérgica: aspectos epidemiológicos, diagnósticos e terapêuticos.J Bras Pneumol. 2008[citado 13 feb 2013]; 34(4):230-240. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132008000400008&lng=en

  18. Pac Sa MR, Museros Recatala L, Arnedo Pena A, Bellido Blasco JB, Puig Barberà J, Artero Sivera A, et al. Factores de riesgo de síntomas de rinitis alérgica en adolescentes de Castellón, España. Rev Panam Salud Pública. 2008[citado 13 feb 2013]; 23(5):333-340. Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000500005&lng=en

  19. Rodríguez Orozco AR, Pérez Sánchez AG, Cardoso Alonso SA, Reyes Retana A. Prevalencia comparada de asma y rinitis alérgica entre niños y adolescentes michoacanos provenientes de escuelas públicas de Morelia. Rev Invest Clín. 2007[citado 13 feb 2013]; 59(1):90-92. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762007000100012&lng=es

  20. Solé D, Wandalsen GF, Camelo Nunes IC, Naspitz Charles K. Prevalência de sintomas de asma, rinite e eczema atópico entre crianças e adolescentes brasileiros identificados pelo International Study of Asthma and Allergies (ISAAC): fase 3. J Pediatr. 2006[citado 13 feb 2013]; 82(5):341-346. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572006000600006&lng=en

  21. Mir E, Panjabi C, Shah A. Impact of allergic rhinitis in school going children. Asia Pacific Allergy. 2012[citado 13 feb 2013]; 2(2):93-100. Disponible en: http://www.apallergy.org/search.php?where=aview&id=10.5415/apallergy.2012.2.2.93&code=9996APA&vmode=FULL

  22. Hardjojo A, Shek LPC, Van Bever HPS, Lee Wah B. Rhinitis in children less than 6 years of age: current knowledge and challenges. Asia Pacific Allergy. 2011[citado 10 feb 2013]; 1(3):115-122. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206246/

  23. Kurukulaaratchy RJ, Karmaus W, Raza A, Matthews S, Roberts G, Arshad SH. The influence of gender and atopy on the natural history of rhinitis in the first 18 years of life. Clin Exp Allergy. 2011[citado 10 feb 2013]; 41(6):851-859.Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2011.03765.x/abstract?deniedAccessCustomisedMessage=&userIsAuthenticated=false 24. Varshney J, Varshney H, Kumar Dutta S, Hazra A, Comparison of sensory attributes and immediate efficacy of intranasal ciclesonide and fluticasone propionate in allergic rhinitis: A randomized controlled trial. Indian J Pharmacol. 2012[citado 13 feb 2013]; 44(5):550-554. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480782/

  24. Zhao J, Bai J, Shen K, Xiang L, Huang S, Chen A, et al. Self-reported prevalence of childhood allergic diseases in three cities of China: a multicenter study. BMC Public Health. 2010 [citado 13 feb 2013]; 10:551. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944377/

  25. Van Adelsberg J, Philip G, LaForce CF, Weinstein SF, Menten J, Malice MP, et al. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2003[citado 13 feb 2013]; 90(2):214-222. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Randomized+controlled+trial+evaluating+the+clinical+benefit+of+montelukast+for+treating+spring+seasonal+allergic+rhinitis.#

  26. Philip G, Malmstrom K, Hampel FC Jr, Wenstein SF, LaForce CF, Ratner PH, et al. Montelukast treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial preformed in the spring.Ciln Exp Allergy. 2002[citado 13 feb 2013]; 32(7):1020-1028. Disponible en: http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2222.2002.01422.x/abstract?deniedAccessCustomisedMessage=&userIsAuthenticated=false

  27. Van Adelsberg J, Philip G, Pedinoff AJ, Meltzer EO, Ratner PH, Menten J, et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.Allergy. 2003[citado 13 feb 2013]; 58(12):1268-1276. Disponible en: http://onlinelibrary.wiley.com/doi/10.1046/j.1398-9995.2003.00261.x/full

  28. Chervinsky P, Philip G, Malice MP, Bardelas J, Nayak A, Marchal JL, et al. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies. Ann Allergy Asthma Immunol. 2004[citado 10 feb 2013]; 92(3): 367-373. Disponible en: http://www.sciencedirect.com/science/article/pii/S1081120610615761

  29. Wandalsen GF, Coppini M, Castro LA, Silva FH, Moya MF, Wandalsen NF. Montelucaste como monoterapia para asma e rinite alérgica persistentes. Rev Bras Alerg Imunopatol. 2006[citado 13 feb 2015]; 29(2): 94-99. Disponible en: http://www.asbai.org.br/revistas/Vol292/montelucaste.pdf

  30. Jacobs R, Lieberman P, Kent E, Silvey, M, Locantore N, Philpot E. Weather/temperature sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. Allergy Asthma Proc. 2009[citado 13 feb 2015] ; 30(2): 120-127. Disponible en: http://www.ingentaconnect.com/content/ocean/aap/2009/00000030/00000002/art00003




2020     |     www.medigraphic.com